Ginkgo Bioworks Holdings Inc Class (DNA)
EBITDA Margin
-220.06%
Quarterly · Period ending:
DNA EBITDA Margin
Latest reported-220.06%period ending
Latest reported-220.06%period ending
DNA Quarterly EBITDA Margin (-59.22% → -220.06%)
Quarterly ebitda margin
High-resolution chart · PNG
DNA ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -220.0635% | |
| -325.2542% | |
| -202.8117% | |
| -171.4499% | |
| -92.8836% | |
| -141.4152% | |
| -327.2379% | |
| -39.4021% | |
| -250.3131% | |
| -403.2548% | |
| -834.2138% | |
| -305.111% | |
| -193.1238% | |
| -230.3896% | |
| -133.3143% | |
| -995.8764% | |
| -456.7779% | |
| -346.4505% | |
| -1,075.5478% | |
| -120.7112% | |
| -108.2867% | |
| -156.0945% | |
| -161.8442% | |
| -165.3962% | |
| -274.2989% | |
| -59.2221% |